Literature DB >> 7696116

Amino acid and carnitine supplementation in haemodialysed children.

J Zachwieja1, M Duran, J A Joles, P J Allers, D van de Hurk, J J Frankhuisen, R A Donckerwolcke.   

Abstract

Plasma carnitine, amino acids and lipids levels were studied in ten uraemic children treated with haemodialysis and given amino acid supplementation with and without carnitine. As carnitine is synthesised from lysine and methionine and has a significant influence on lipid metabolism, the relationship between these was examined. Amino acid supplementation (0.25 g/kg body weight) was started with the intention of improving the plasma amino acid pattern in these children and increasing the concentration of lysine, which is the substrate for carnitine synthesis. Amino acids were administered i.v. during dialysis and carnitine (25 mg/kg body weight i.v.) was administered after dialysis three times a week. Concentrations of most essential amino acids were decreased in these patients. The first period of amino acid supplementation did not increase plasma levels of the essential amino acids, with the exception of tyrosine (P < 0.01). After the second period of supplementation, methionine was increased (P < 0.01), isoleucine was decreased (P < 0.01), but tyrosine normalised and was significantly lower than after the first period (P < 0.05). Thus overall amino acid supplementation did not improve amino acid levels; it was inconsistently associated with a further decrease in high-density lipoprotein-cholesterol and an increase in total protein levels. Lysine concentrations after amino acid supplementation remained low. Paradoxically, before carnitine supplementation a positive correlation between free carnitine and triglycerides was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7696116     DOI: 10.1007/bf00869107

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects.

Authors:  S Ahmad; H T Robertson; T A Golper; M Wolfson; P Kurtin; L A Katz; R Hirschberg; R Nicora; D W Ashbrook; J D Kopple
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

Review 2.  Lipid abnormalities in renal disease.

Authors:  G Appel
Journal:  Kidney Int       Date:  1991-01       Impact factor: 10.612

Review 3.  Carnitine metabolism in chronic renal failure.

Authors:  G Guarnieri; G Toigo; L Crapesi; R Situlin; M A Del Bianco; M Corsi; P LoGreco; G Paviotti; G Mioni; L Campanacci
Journal:  Kidney Int Suppl       Date:  1987-10       Impact factor: 10.545

4.  Free plasma and muscle amino acids in uremic children.

Authors:  C Delaporte; G Jean; M Broyer
Journal:  Am J Clin Nutr       Date:  1978-09       Impact factor: 7.045

5.  Plasma carnitine concentrations and dyslipidemia in children on maintenance hemodialysis.

Authors:  R Gusmano; R Oleggini; F Perfumo
Journal:  J Pediatr       Date:  1981-09       Impact factor: 4.406

6.  Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.

Authors:  A Glöggler; M Bulla; P Fürst
Journal:  Kidney Int Suppl       Date:  1989-11       Impact factor: 10.545

7.  Amino acid losses during hemodialysis with infusion of amino acids and glucose.

Authors:  M Wolfson; M R Jones; J D Kopple
Journal:  Kidney Int       Date:  1982-03       Impact factor: 10.612

8.  Plasma and muscle free amino acids in uremia: influence of nutrition with amino acids.

Authors:  A Alvestrand; P Fürst; J Bergström
Journal:  Clin Nephrol       Date:  1982-12       Impact factor: 0.975

9.  Plasma carnitines: reference values in an ambulatory population.

Authors:  O Boulat; B Janin; P Francioli; C Bachmann
Journal:  Eur J Clin Chem Clin Biochem       Date:  1993-09

10.  The effect of oral essential amino acids and their ketoanalogues on children receiving regular haemodialysis.

Authors:  M Bulla; H J Bremer; R Ronda-Vildozola; B Roth
Journal:  Int J Pediatr Nephrol       Date:  1986 Apr-Jun
View more
  5 in total

Review 1.  The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors:  Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2005-12-23       Impact factor: 3.714

2.  Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis.

Authors:  Enrico Verrina; Ubaldo Caruso; Maria Grazia Calevo; Francesco Emma; Palma Sorino; Tommaso De Palo; Giancarlo Lavoratti; Laura Turrini Dertenois; Michela Cassanello; Roberto Cerone; Francesco Perfumo
Journal:  Pediatr Nephrol       Date:  2007-02-03       Impact factor: 3.714

3.  Carnitine supplementation improves cardiac strain rate in children on chronic hemodialysis.

Authors:  Kristen Sgambat; Lowell Frank; Ahmad Ellini; Craig Sable; Asha Moudgil
Journal:  Pediatr Nephrol       Date:  2012-03-22       Impact factor: 3.714

Review 4.  Nutrition aspects in children receiving maintenance hemodialysis: impact on outcome.

Authors:  Poyyapakkam R Srivaths; Craig Wong; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2008-02-22       Impact factor: 3.714

Review 5.  Nutrition in children with CRF and on dialysis.

Authors:  Lesley Rees; Vanessa Shaw
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.